---
schema_version: "secwatch.filing_event.v1"
accession: "0001517022-26-000075"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2026-10-23T20:06:26+00:00"
generated_at: "2026-10-23T20:07:03.036680+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Akebia gets Nasdaq deficiency letter as stock closes below $1.00 for 30 straight days

## Summary
- Nasdaq Listing Qualifications notified Akebia on October 21, 2026 that its bid price closed under $1.00 for 30 consecutive business days, breaching Rule 5550(a)(2).
- Akebia has until April 19, 2027 (180 calendar days) to regain compliance by holding a closing bid of at least $1.00 for 10 straight business days.
- If it fails, Akebia could get a second 180-day period by meeting market-value and other initial listing standards and signaling a reverse split if needed.
- The notice has no immediate effect on listing; Akebia said it will monitor its bid price and may pursue a reverse stock split, with no assurance of regaining compliance.
- CEO John P. Butler signed the filing dated October 23, 2026; continued failure could lead to a Staff delisting determination and appeal to a Nasdaq Hearings Panel.

## SEC filing metadata
- accession: 0001517022-26-000075
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2026-10-23T20:06:26+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000151702226000075/0001517022-26-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000151702226000075/akba-20261021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001517022-26-000075
- JSON: https://secwatch.observer/filing/0001517022-26-000075.json
- Plain text: https://secwatch.observer/filing/0001517022-26-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.